TABLE 2.
Comparison of the method developed here with other approaches for expression of heterologous selenoproteins in E. coli
FDH is formate dehydrogenase; EF-Tu is elongation factor Tu.
Approach | Selenoproteins expressed | Proof of Sec incorporation | Specificity in Sec incorporation | Total yield of selenoprotein | Competing events reported | Refs. |
---|---|---|---|---|---|---|
16S rRNA mutations for improved Sec insertion efficiency at the ribosome | Luciferase reporter downstream of SECIS element, endogenous FDH | Luciferase activity of reporter, benzyl viologen assay, for endogenous FDH activities | Best mutants, ≈30% | Unclear, not quantified | UGA truncation, Trp-mediated UGA suppression | Thyer et al. (31) |
Synthetic tRNAUtu species for EF-Tu-mediated Sec insertion at either UGA or UAG codons | Endogenous FDH, GPx1 or Sec-substituted Grx1 | Benzyl viologen assay for endogenous FDH, mass spectrometry of Grx1, enzyme activities of Grx1 and GPx1 | ≈50–65% (Sec-Grx1 vs. Ser-Grx1 or Sec-GPx1 vs. Ser-GPx1), double activity of Sec-Grx1 vs. Cys-Grx1, GPx1 ≈6 units/mg | Unclear, not quantified | Ser-mediated suppression | Aldag et al. (28) |
SelB-mediated suppression of alternative codons using tRNASec variants with altered anticodon sequences | Endogenous FDH, human TrxR1 | Benzyl viologen assay for endogenous activities of FDH and specific activities of purified FDH, mass spectrometry, specific activity of TrxR | FDH, 12–100% depending upon codon usage; TrxR ≈95–98% | FDH, up to 12-fold levels of endogenous wild type FDH; TrxR unclear, not quantified | Unclear, codon-dependent | Bröcker et al. (29) |
Engineered tRNASec for EF-Tu-mediated Sec insertion at UAG, also tested in the RF1- depleted C321.ΔA host | Sec-substituted NMC-A β-lactamase, endogenous FDH, Sec-substituted DHFR, Sec-substituted azurin, human GPx1 | Antibiotic resistance due to functional β-lactamase, benzyl viologen assay for endogenous FDH, mass spectrometry | Sec-DHFR, ≈100%, other selenoproteins produced unclear specificity | Unclear, not quantified | Ser-mediated suppression | Thyer et al. (32) |
Further engineered tRNASec for EF-Tu-mediated Sec insertion at UAG with lower Ser-mediated suppression | Endogenous FDH, Sec-substituted Grx1 | Benzyl viologen assay for endogenous FDH, specific activities of FDG and Sec-substituted Grx1, mass spectrometry | FDH, ≈70%; Grx1, ≈100% | Unclear, not quantified using expression in vivo; in cell-free systems ≈2–80 ng obtained per reaction depending upon construct | Ser-mediated suppression | Miller et al. (30) |
UAG-directed Sec insertion in RF1-depleted host, with or without bacterial SECIS element | Rat and human TrxR isoenzymes, human GPx1 | Enzyme activities and mass spectrometry | With SECIS, ≥95%. No SECIS, ≈30%. TrxR1 ≈35–40 units/mg. GPx1 ≈10 units/mg | With SECIS, ≈20 mg/liter. No SECIS, 1–3 mg/liter | UAG-directed truncation, Gln- and Lys-mediated suppression | This work |